A PYMNTS Company

US: Appeals court overturns vitamin C price fixing verdict

By  |  September 20, 2016

On Tuesday, the 2nd U.S. Circuit Court of Appeals in New York threw out a verdict fining two Chinese companies $147.8 million. The fine was given to Hebei Welcome Pharmaceutical Co and North China Pharmaceutical Group Corp for conspiring to fix prices and the supply of Vitamin C from December 2001 to June 2006.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The court stated that the case should never have gone to trial after China issued a statement to the presiding judge that Chinese laws required the companies to violate the Sherman Act. The Court of Appeals said that the judge who issued the fine should have deferred to China’s interpretation of its own laws since there are enormous differences between US and Chinese legal and economic regulations.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Full Content: CNBC

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.